Industry Research by Koncept Analytics Global Glaucoma Market: Industry Analysis & Outlook ----------------------------------------- (2017-2021) May 2017 1
Executive Summary Glaucoma is a group of eye diseases which result in damage to the optic nerve and vision loss. The most common type is open-angle glaucoma with less common types including closed-angle glaucoma and normaltension glaucoma. Open-angle glaucoma develops slowly over time and there is no pain. Side vision may begin to decrease followed by central vision resulting in blindness, if not treated. Closed-angle glaucoma can present gradually or suddenly. The sudden presentation may involve severe eye pain, blurred vision, middilated pupil, redness of the eye, and nausea. Vision loss from glaucoma, once it has occurred, is permanent. Though, glaucoma cannot be cured completely but the disease progression can be controlled with the help of available treatments. There are three types of modalities available for treatment of glaucoma: Drugs, Laser and Invasive Surgery. Further, based upon the approaches employed for the medication, it can be segmented into two parts: PGA Medication and Non-PGA Medication. The PGA approach reduces IOP with the help of prostaglandin (PGA). The non-pga medication can be further divided into four sub segments: Beta blockers, Alpha blockers, Carbonic anhydrase inhibitors (CAIs) and Combination Products. Several factors such as rising prevalence of diabetes, growing geriatric population and rising health care expenditure along with increasing disposable income and growing obese population will drive the market growth in the next few years. Development of new drugs & devices and drug therapy focused upon IOP are the few notable market trends. However, high cost of treatment, severe side effects and hasty drug approval processes act as a major roadblock for the market growth. The report analyzes the development of this market, with focus on the US and OUS treatment market. The major trends, growth drivers as well as issues being faced by the market are discussed in detail in this report. The four major players: Pfizer Inc., Novartis AG, Merck & Co., Inc. and Allergan Plc. are being profiled along with their key financials and strategies for growth. The report contains a comprehensive analysis of the global glaucoma market along with the study of the US market. 2
US$ Billion US$ Billion For the past few years, global glaucoma market has been growing rapidly with increasing number of people with glaucoma and introduction of innovative treatment options. Factors such as rising geriatric population and rise in healthcare expenditure will help the market to grow in the next few years. Global Glaucoma Market Forecast by Value (2016-2021) In 2016, the global glaucoma market was recorded at US$... billion and is expected to reach US$... billion by the end of 2021, growing at a CAGR of %, spanning from 2016 to 2021. In 2016, the global glaucoma drugs market was valued at US$... billion and is predicted to reach US$... billion by the end of 2021, growing at a CAGR of %, spanning from 2016 to 2021. In year 2016, with % share of the market, drugs continued to dominate due to high dependency of patients upon drugs, followed by others with % share. Global Glaucoma Drugs Market Forecast by Value (2016-2021) Global Glaucoma Market by Segments (2016) Drugs Others (Surgery & Laser) 3
US$ Billion US$ Billion The U.S. is considered to be one of the largest markets for glaucoma treatment. Factors such as launch of new drugs and therapies in the late 2010s, rising geriatric population and healthcare expenditure will act as growth driver for the market. The US Glaucoma Drugs Market Forecast by Value (2016-2021) In 2016, the US glaucoma drugs market was valued at US$... billion and is predicted to reach US$... billion by the end of year 2021, growing at a CAGR of nearly %, spanning from 2016 to 2021. In 2016, OUS glaucoma drugs market was recorded at US$... billion and is expected to reach US$... billion by the end 2021, growing at an CAGR of %, spanning from 2016 to 2021. As of 2016, the US continued to remain as the bigger glaucoma drugs market and solely accounted for % share, while the remaining share was attributable to the regions outside the US. OUS Glaucoma Drugs Market Forecast by Value (2016-2021) Global Glaucoma Drugs Market by Region (2016) The US OUS 4
Contact Us: Disclaimer This is a licensed product of Koncept Analytics. You cannot reproduce, publish, distribute, publicly display, sell or create other works from this report or use them in any way for commercial purpose without our prior permission. Further, you cannot copy this material, by any means (including electronic copies), for distribution to others unless you have purchased the corporate license of this report. We believe the sources are reliable, but Koncept Analytics does not warranty the accuracy or completeness of the data. The data presented in the report is updated at the publication date but is subject to change at subsequent releases. All possible efforts have been made to ensure accuracy of data. However, investors should not completely rely on the information given in this report and must make decisions based on their own investment strategy, risk management and capital adequacy. Koncept Analytics CS-36, First Floor, Ansal Plaza Vaishali, Ghaziabad, U.P. 201010 T: +91-120-4130959 M: +91-9811715635 vikas@konceptanalytics.com www.konceptanalytics.com 5